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Abstract: Patients with certain neurological diseases are at increased risk of developing chest 
infections as well as respiratory failure due to muscular weakness. In particular, patients with 
certain neuromuscular disorders are at higher risk. These conditions are often associated with 
sleep disordered breathing. It is important to identify patients at risk of respiratory complications 
early in the course of their disease, although patients with neuromuscular disorders often present 
in the acute setting with respiratory involvement. This review of the respiratory complications 
of neurological disorders, with a particular focus on neuromuscular disorders, explores why this 
happens and looks at how to recognize, investigate, and manage these patients effectively.
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Introduction
Many different types of neurological disorders can affect respiratory function (see 
Table 1). Neuromuscular disorders in particular have a propensity to affect respiratory 
function adversely and are characterized by either disease of a muscle itself or the 
nerve(s) supplying that muscle, and this will form the focus of this review, although we 
will touch upon other respiratory complications of neurological disease. Neuromuscular 
disorders are commonly encountered in both the acute and outpatient setting, and are 
typically characterized by progressive muscular impairment. This can lead to loss 
of mobility and in some instances patients become wheelchair-bound, experiencing 
significant respiratory muscle weakness, which is a common cause of death from 
respiratory failure, often associated with aspiration and pneumonia.1 Furthermore, 
their ability to protect their own airway can become compromised, leading to chest 
infections. There is also a close association with sleep-disordered breathing which can 
lead to significant morbidity and precede daytime ventilatory failure.2 Unfortunately, 
many neurological disorders that affect respiratory function remain incurable, and 
therefore the broad aim when managing such patients is to help maintain and improve 
both physical and psychosocial function, including respiratory function.
Some disorders deteriorate acutely within days to weeks, such as Guillain-Barré 
syndrome and myasthenia gravis. Muscle disorders including Duchenne muscular 
dystrophy and myotonic dystrophy progress more slowly, whilst amyotrophic lateral 
sclerosis, an anterior horn cell disease, has a more rapid progression.
Although there are case reports of patients with neuromuscular disorders such 
as myasthenia gravis presenting as isolated respiratory failure, in most neuromus-
cular   disorders, respiratory failure develops during the course of the disease.3,4 
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
255
REvIEW
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJGM.S26333International Journal of General Medicine 2012:5
Therefore, when managing patients with neurological 
  disorders and in particular neuromuscular disorders, both in 
the acute or chronic phase, it is important to be vigilant to 
the possibility of respiratory muscle involvement.
Materials and methods
We conducted a detailed search of the current literature 
comprising systematic reviews, using sources including 
the Cochrane Collaboration alongside a PubMed search for 
existing clinical reviews and randomized controlled trials 
of relevance. We also reviewed existing guidelines and 
consensus opinion, including those of the British   Thoracic 
Society, American Academy of Sleep Medicine, and 
  American Academy of Neurology.
Why do neuromuscular disorders 
cause respiratory failure?
The diaphragm is the main muscle responsible for respiration and 
contributes almost 70% to inspiratory tidal volume in a normal 
individual.5 It is innervated by the phrenic nerve, originating 
at spinal nerve roots C3 through to C5. External intercostal 
muscles and accessory muscles (sternocleidomastoid, scalene, 
trapezius, latissimus dorsi, pectoralis major and minor, and 
platysma) assist inspiration when there is increased load on 
the respiratory system, such as during exercise or an asthma 
attack. Internal intercostal muscles and abdominal muscles 
largely support exhalation and aid the cough reflex. The bulbar 
muscles allow the upper airway to remain patent.
Respiratory muscle weakness decreases airflow, causing a 
gradual decline in vital capacity (the maximum amount of air 
that can be expelled after maximal inspiration) and patients 
are unable to inhale deeply. The load on the respiratory 
system is increased at lower volumes because the lungs do 
not expand as easily. This eventually affects gas exchange 
with ventilation-perfusion mismatch ensuing.6 The increased 
load on the respiratory system and muscle weakness results in 
patients developing a rapid and shallow breathing pattern.
Early evidence of respiratory system involvement in 
patients with a neuromuscular disorder is first seen during 
sleep. During rapid eye movement sleep, the respiratory 
drive is momentarily decreased and hypotonia of accessory 
respiratory muscles is seen. Patients with respiratory muscle 
weakness therefore develop nocturnal O2 desaturation and 
hypercapnia.1 The degree of nocturnal desaturation correlates 
to the degree of diaphragmatic weakness.
These factors result in hypoventilation, carbon dioxide 
(CO2) retention and type 2 respiratory failure.3 Because of a 
considerable reserve of ventilatory function, respiratory failure 
is often not seen until respiratory muscle strength has fallen to 
25%–30% of normal.5 Because patients with neuromuscular 
disorders often have a compromised respiratory reserve, 
they tend to decompensate much more easily when under 
additional stress. The fact that such patients are more prone 
to chest infections demonstrates the significant association 
between neuromuscular disorders and respiratory failure.
Patients with certain neuromuscular disorders, such as 
spina bifida, poliomyelitis, and some muscular dystrophies, 
also have an element of kyphoscoliosis, which could be 
congenital, related to a degenerative condition of the spine, 
or a result of previous trauma/surgery. This can worsen 
pulmonary restriction and respiratory impairment caused by 
an associated neurological condition and therefore lead to 
earlier and more severe respiratory compromise.
Why do patients with certain 
neurological disorders develop  
chest infections?
Pneumonia is a common complication in patients both with 
acute neurology (eg, cerebrovascular accident) and chronic 
Table 1 Neurological disorders affecting respiratory function
Location Disease
Cerebral cortex Stroke (aspiration) 
Neoplasm 
Seizures (aspiration)
Brain stem Multiple sclerosis
Basal ganglia Parkinson’s disease
Spinal cord Multiple sclerosis 
Trauma 
Tetanus 
Neoplasm/cord compression
Anterior horn cell Spinal muscular atrophy* 
Post-polio syndrome* 
Amyotrophic lateral sclerosis* 
Toxins (lithium)
Peripheral nerve Guillain-Barré syndrome* 
Porphyria* 
Critical illness polyneuropathy*
Neuromuscular  
junction
Myasthenia gravis* 
Acid maltase deficiency* 
Toxins (botulism)* 
Drugs, eg, corticosteroids, anticholinesterase 
inhibitors
Myopathies Congenital muscular dystrophy* 
Limb girdle muscular dystrophy* 
Myotonic dystrophies* 
Duchenne muscular dystrophy* 
Polymyositis* 
Critical illness myopathy* 
Hypokalemia* 
Rhabdomyolysis*
Note: *Neurological disorders likely to cause respiratory muscle weakness.
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neurological conditions (eg, multiple sclerosis). It is thought 
that 20% of deaths in patients with Parkinson’s disease are 
due to pneumonia, possibly due to an impaired cough and 
involvement of the muscles of the upper airway.7 Weakness 
of the facial, oropharyngeal, and laryngeal muscles can 
result in a compromised swallow and secretion clearance. 
  Weakness of these muscles can also compromise the airway 
due to physical obstruction, particularly when lying flat.8 The 
cough reflex is diminished due to weakness of the abdominal 
muscles, once again increasing the risk of aspiration. This 
leads to increased risk of developing infections as well as 
delaying recovery.
Assessing a patient for possible 
neuromuscular weakness
Acute neuromuscular respiratory disease
If a patient presents with acute weakness, it is important to 
establish any possible respiratory muscle weakness placing 
the patient at risk of respiratory failure or bulbar weakness 
which may lead to aspiration pneumonia. Dyspnea   associated 
with lying flat or whilst immersed in water specifically 
indicates diaphragmatic weakness. This is an important 
symptom and reflects a major (70%) contribution of the 
diaphragm muscles to the inspiratory tidal volume.5
Bulbar dysfunction is associated with a poor swallow, 
dysarthria, weak mastication, facial weakness, nasal speech, 
and/or a protruding tongue. It is essential to establish early 
respiratory involvement in patients with rapid onset weakness 
involving the bulbar muscles or shoulder girdle5 in order to 
anticipate the need for mechanical ventilation, such as in 
patients with Guillain-Barré syndrome.
Chronic neurological disorders  
and respiratory disease
In patients with chronic neurological disorders it is important 
to establish nocturnal symptoms:
•	 Is the patient’s sleep often disturbed? If so, what causes 
them to arouse?
•	 Do they wake up with choking sensations?
•	 Do they wake up with a headache first thing in the 
morning?
•	 Are they especially tired during the day?
These questions may suggest nocturnal hypoventilation3 
which is an early sign of respiratory muscle weakness. It is 
important to note that patients with neuromuscular disorders 
may have poor mobility and therefore do not necessarily 
present with exertional dyspnea.
Signs
The immediate focus should be to observe for signs 
of respiratory distress (Table 2). Examine the patient 
for evidence of any spinal abnormalities like kyphosis. 
Observe for paradoxical abdominal movement (inward 
abdominal movement on inspiration) which usually suggests 
considerable weakness of the diaphragm muscle. Cranial 
nerve and peripheral neurological examination is useful to 
look specifically for the following signs:
•	 Dysphagia, dysphonia, drooling
•	 Cough after swallowing indicating aspiration
•	 A weak cough.
The single-breath test can be useful in exploring the 
extent of impairment of a patient’s vital capacity. This test is 
  performed by asking the patient to take a maximal inspiratory 
breath and begin counting. Normal patients can reach up to 
50, but severe impairment of vital capacity is indicated by a 
single-breath count of ,15.8
Investigations
Chest x-ray
A chest radiograph can be helpful not only in identifying 
associated respiratory problems such as kyphoscoliosis 
and emphysema, which may be contributing to respiratory 
compromise, but also precipitating factors for respiratory 
decompensation, such as respiratory infections (including 
aspiration pneumonia), pulmonary edema, and atelectasis. 
A raised hemidiaphragm may be caused by unilateral phrenic 
nerve palsy which is usually well tolerated.   However, 
a bilateral raised hemidiaphragm in patient with motor 
  neuron disease may need further investigation with a sniff 
test or phrenic nerve stimulation to establish diaphragmatic 
weakness/paralysis.9
Arterial blood gases
Arterial blood gas derangement is mainly seen during the 
latter stages of a neuromuscular disorder with respiratory 
involvement or when there is an acute respiratory insult. 
Arterial blood gas measurement helps to confirm hypoxia 
Table 2 Signs of respiratory distress
Tachypnea
Unable to complete sentences
Restless or drowsy
Leaning forward
Cyanosis
Use of accessory muscles including sternocleidomastoid muscles
Intercostal recession – indrawing of intercostal spaces during inspiration
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(PaO2 , 11 kPa) in patients presenting with low SaO2 and to 
determine type 1 or 2 respiratory failure as a cause of hypoxia 
(Table 3). A raised pCO2 . 45 mmHg (6 kPa) in the acute or 
stable patient, especially in the presence of acidosis, requires 
immediate assessment for invasive or noninvasive ventila-
tion.10 Metabolic or mixed acidosis with raised lactate points 
to associated sepsis. In patients with a normal daytime SaO2, 
elevated serum bicarbonate with a normal pO2 and pCO2 can 
be suggestive of nocturnal hypoventilation.5
Swallow assessment
Neuromuscular disorders causing respiratory muscle 
  weakness may also affect the muscles controlling the swallow 
reflex. A simple bedside swallow test with foods and liquids 
of different consistencies in the acute setting and subsequent 
visual swallow assessment using video fluoroscopy in a stable 
patient by a speech and language therapist helps to identify 
impaired swallowing. However, swallow assessments by 
a nontrained health care worker can be harmful. Swallow 
assessments by trained nurses working out of hours (eg, 
stroke nurses, night nurse practitioners) can help to avoid 
long periods without appropriate nutrition.
Respiratory function test
Lung function measurement is useful both in the stable 
patient with a chronic neuromuscular disorder to diagnose 
and monitor progression of respiratory muscle weakness 
and in the acute setting to determine the need for invasive 
or noninvasive ventilation.
Spirometry
Neuromuscular disorders typically result in a restrictive 
lung defect on simple spirometry (forced expiratory   volume 
in one second/forced vital capacity ratio . 0.7). The vital 
capacity should be measured in both the upright and supine 
positions. A decline in vital capacity by more than 15%–20% 
in the supine position indicates diaphragmatic weakness.5 
Spirometry can be performed at the bedside using simple 
handheld spirometers in acutely ill patients and in the lung 
function laboratory in stable patients. Serial bedside spirometry 
measurement is particularly useful in the acute setting for 
patients with   rapidly progressing neurology, such as Guillain-
Barré   syndrome, to monitor for deterioration. A value of less 
than 15 mL/kg should prompt urgent intensive care referral for 
endotracheal intubation in anticipation of potential respiratory 
arrest. However, validity of the results is very dependent on 
technique, and not all patients can understand or generate 
sufficient effort. Furthermore, spirometry measurement can 
vary in neuromuscular disorders with   variable/intermittent 
muscle weakness such as myasthenia gravis. Spirometry 
measurements can therefore be a poor predictor of the 
need for mechanical ventilation is such patient groups.11 In 
patients with a stable neuromuscular disorder, no single test 
can   reliably diagnose or predict early respiratory muscle 
  weakness.12 Therefore, a combination of measures, including 
vital capacity and mouth pressures, are required.
Mouth pressures
Mouth pressures (inspiratory and expiratory) represent global 
inspiratory and expiratory respiratory muscle strength.13 
Maximum inspiratory pressure reflects the strength of the 
diaphragm, external intercostal muscles, and accessory 
muscles, whereas maximum expiratory pressure represents 
expiratory muscle and cough strength. Mouth pressures 
with vital capacity should be measured early in all patients 
with neuromuscular disorders associated with respiratory 
muscle weakness to establish a baseline. Patients with 
reduced mouth pressures, maximum inspiratory pressure 
of ,60% predicted (normal value for males . 80 cm H2O, 
females . 70 cm H2O) required close respiratory follow-up 
for serial measurements and further investigation including 
arterial blood gas measurement.5 Mouth pressures can also 
provide an additional objective measurement to decide on 
the need for mechanical ventilation8 in the acute setting 
(Table 5). However, measurement of mouth pressure requires 
the patient to make an adequate seal around the mouthpiece 
which may not always be possible in patients who have facial 
muscle weakness.
Sniff nasal inspiratory pressure
Sniff nasal inspiratory pressure is an additional test for 
measurement of inspiratory muscle strength and can be used 
in conjunction with maximum inspiratory pressure. A sniff 
nasal inspiratory pressure  70 cm H2O ( 60 cm H2O for 
females) makes significant respiratory muscle weakness 
unlikely. A combination of tests like sniff nasal inspiratory 
pressure and maximum inspiratory pressure increases 
diagnostic precision.14
Table 3 Arterial blood gas patterns in respiratory failure
pH PaO2 PaCO2 Bicarbonate
Type 1 RF Normal/high Low Normal/low Normal
Acute type 2 RF Normal/low Low High Normal/rising
Acute on chronic 
type 2 RF
Normal/low Low High Raised
Abbreviation: RF, respiratory failure.
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Sleep studies
Patients with neuromuscular disorders are at increased risk 
of sleep-disordered breathing which includes disorders such 
as obstructive sleep apnea and nocturnal hypoventilation.2 
  Nocturnal desaturations and sleep disturbance usually pre-
cede daytime respiratory failure and should be investigated 
early.2 In patients suspected to have nocturnal hypoventila-
tion, overnight oximetry can be performed. This is a simple 
investigation which measures oxygen saturation overnight 
with a pulse oximeter. It can establish underlying hypoventila-
tion and is useful in asymptomatic patients with chronic dis-
ease in whom early respiratory failure is suspected. Overnight 
oximetry parameters helpful for confirmation of nocturnal 
hypoventilation are SaO2 , 90% for .30% of sleep dura-
tion. A prolonged SaO2 desaturation pattern (SaO2 , 90% 
for continuous five minutes) is characteristic of nocturnal 
hypoxia due to hypoventilation as opposed to the frequent 
repetitive desaturations of a saw tooth pattern observed in 
patients with obstructive sleep apnea. Some patients may 
develop obstructive sleep apnea prior to developing alveolar 
hypoventilation.
Polysomnography/polygraphy (multichannel) sleep study 
with continuous transcutaneous carbon dioxide tension 
monitoring should be considered when overnight oximetry 
is indeterminate.15 Respiratory parameters of nasal flow are 
measured with a nasal pressure transducer, and chest and 
abdominal excursion is measured with respiratory inductive 
plethysmography bands. This helps to differentiate between 
nocturnal hypoxia due to hypoventilation and sleep apnea. 
These parameters are also able to characterize sleep apnea 
into a central and obstructive type. Transient increases in 
transcutaneous CO2 (pCO2  50 mmHg for 5% of study 
time) is a definite parameter for identification of nocturnal 
hypoventilation in patients with neuromuscular disorders.
It is not clear when the most favorable time is to undertake 
a sleep study during a patient’s disease course. However, 
there should a low threshold for screening with overnight 
oximetry in patients with a severe restrictive impairment 
(vital capacity , 50% of predicted) and/or patients with a his-
tory of disturbed sleep, early morning headaches, or daytime 
fatigue/tiredness/sleepiness.16 There is current interest in the 
use of symptom-based, self-administered screening question-
naires to identify patients with a neuromuscular disorder and 
at risk of sleep-disordered breathing who may benefit from 
polysomnography and intervention with mechanical ventila-
tion, although more research is required in this area.17
The role of sleep studies is therefore to determine the 
presence of sleep-disordered breathing, and the American 
Academy of Sleep Medicine suggests that for patients with 
neuromuscular disorders and sleep-related symptoms, poly-
somnography is routinely indicated to evaluate symptoms of 
sleep disorders that are not adequately diagnosed by obtain-
ing a sleep history, assessing sleep hygiene, and reviewing 
sleep diaries.18
Different patterns may be observed with specific neuro-
muscular disorders. For example, with amyotrophic lateral 
sclerosis, nocturnal hypoventilation and oxygen desaturation 
are the main abnormalities detected on polysomnography, 
with apnea/hypopneas being less common.10 The main 
problem is thought to be due to diaphragmatic weakness 
and hypoventilation rather than obstructive sleep apnea 
secondary to bulbar events.2 Thirty-six percent of patients 
with myasthenia gravis have been found to have obstructive 
sleep apnea in one series,19 with desaturations and sleep-
disordered breathing being more common during rapid eye 
movement sleep.2
Degenerative central nervous system disorders like 
  multiple sclerosis or Parkinson’s disease have been   associated 
with sleep-disordered breathing. Multiple sclerosis affecting 
the medullary tegmentum can lead to obstructive sleep 
apnea, whilst Parkinson’s disease has been associated with 
central apnea and hypoventilation, thought to be secondary 
to autonomic dysfunction.7
Management of respiratory 
complications of neurological 
disorders
Immediate management
Immediate priorities in patients presenting with respiratory 
failure due to neurological disorders are airway manage-
ment, oxygenation, and prompt treatment of precipitating 
factors, such as pneumonia, in addition to assessment for 
more specialized therapies.
The oxygen concentration (FiO2) required for oxygenation 
depends on the presence of type 1 or type 2 respiratory failure 
and the desired target oxygen saturation (Table 4). Arterial 
Table 4 Oxygen management in respiratory failure, based on 
2008 British Thoracic Society guidelines for emergency oxygen 
use in adult patients20
Type 1 respiratory failure Deliver concentration of oxygen that 
maintains saturations between 94%–98%
Type 2 respiratory failure 
or at risk of type 2 failure
Deliver minimum concentration of  
oxygen that maintains saturations 
between 88%–92%
Note: Reproduced from Thorax, B O’Driscoll, L Howard, AG Davidson, 63, Suppl 6: 
1–12, 2008 with permission  from BMJ Publishing Group Ltd.
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blood gases should be repeated following initiation of oxygen 
or changing FiO2. In patients with type 2   respiratory failure, the 
conventional wisdom was that they are reliant on a “hypoxic 
drive” and that high concentrations of oxygen abolished this 
drive. This, in turn, reduces the ventilatory drive and worsens 
hypercapnia. However, it is now known that the process is much 
more complicated and is related to impaired matching of blood 
and gas flow in the lungs.20 A Venturi mask system should be 
used to deliver a fixed oxygen concentration with the aim of 
using the minimum concentration of oxygen   possible to achieve 
a lower target saturation. However, patients with significant 
hypoxia (SaO2 , 85%) and not at risk of type 2 respiratory 
failure should be started on high-flow oxygen (eg, 10–15 L/min-
ute with a reservoir bag).20 Patients who are unable to maintain 
satisfactory oxygen saturation or are acidotic despite maximal 
medical therapy often require ventilatory support (ie, intubation 
and mechanical ventilation or noninvasive ventilation).
Invasive ventilation
Invasive ventilation in the acute setting should be considered 
in patients who are candidates for treatment in an intensive 
care unit. Patient wishes, baseline function, comorbidities, 
and assessment of successful extubation and restoration of a 
reasonable quality of life need to be considered prior to invasive 
ventilation. Some of the parameters which are useful in decid-
ing on the need for mechanical ventilation are listed in Table 5. 
Patients with acute progressive muscular   weakness as a result 
of, eg, Guillain-Barré syndrome, are usually good candidates for 
intubation, and mechanical ventilation is appropriate. However, 
the decision to intubate should be semielective because emer-
gency intubation is associated with a higher complication rate, 
particularly in patients with Guillain-Barré syndrome because of 
associated autonomic dysfunction and labile blood pressure.8
Acute noninvasive ventilation
The role of nocturnal noninvasive ventilation in patients 
with a neuromuscular disorder and respiratory failure has 
increased over the last 20 years, and indications include 
offering support during an intercurrent chest infection, 
preventing respiratory decompensation, and providing pal-
liation during end-of-life care.21 It has been shown to prolong 
survival in patients with hypercapnic respiratory failure.22 
Noninvasive ventilation can be initiated acutely to treat 
respiratory failure, especially type 2 failure, either to avoid 
endotracheal intubation or when endotracheal intubation is 
deemed inappropriate.
Long-term ventilation
It is important to take a holistic approach and to identify 
health care professionals who need to be involved early on. 
There is a definite role for invasive ventilation via tracheos-
tomy in selected patients with long-term neuromuscular dis-
orders in whom noninvasive ventilation is contraindicated 
or has failed. This requires very careful planning, and some 
patients may decline invasive ventilation, with the negative 
impact on quality of life outweighing the benefits of an 
extended life.21 Patients may find greater difficulty com-
municating, and there is a significant psychological impact 
on patients and carers,23 but survival can be prolonged for 
many years, with some patients suffering from amyotrophic 
lateral sclerosis surviving up to 10 years longer.24 A review 
by Sancho et al,25 based on their experiences at a specialist 
respiratory care unit, looked at 76 subjects with amyo-
trophic lateral sclerosis and respiratory failure, of whom 
38 refused tracheostomy. Over half were initiated during 
an acute episode after failure of noninvasive ventilation, 
and benefits included the ability to clear tracheobronchial 
secretions, with almost 80% surviving at one year. This is 
an option that should be discussed with the patient, and the 
most appropriate time to do this depends on the patient’s 
clinical progression and wishes.
With regards to long-term noninvasive ventilation, 
although we know how neuromuscular disorders involving the 
chest progress to respiratory failure as outlined in Figure 1, 
there remain unanswered questions as to the best moment 
to commence noninvasive ventilation.26 Ideally, it should be 
planned and not implemented as an emergency. A study in a 
group of patients with Duchenne muscular dystrophy trialed 
noninvasive ventilation before the development of nocturnal 
hypoventilation or daytime respiratory failure and found that 
there was no survival benefit or delay in progression and, 
in fact, it adversely affected quality of life.28 A study initiating 
noninvasive ventilation for nocturnal hypoventilation, which 
included patients with neuromuscular disorders, found that 
it may reduce the frequency of hypercapnic episodes and 
Table 5 Predictors of the need for mechanical ventilation8
Onset of bulbar symptoms
Inability to raise arms/elbow above head or inability to stand in Guillain-
Barré syndrome
Rapid progression of muscular weakness
vC , 15 mL/kg or vC , 1 liter
A 50% reduction of vC from admission
Maximum inspiratory pressure . -30 cm H2O
Maximum expiratory pressure , 40 cm H2O
Note: Partially based on data from reference 8.
Abbreviation: vC, vital capacity.
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therefore avoid hospital admissions,27 but that patients have 
a more pronounced response when they are also experiencing 
daytime symptoms. A Cochrane review in 2007 concluded 
that further research is needed to establish the long-term 
benefits of nocturnal mechanical ventilation, including its 
impact on survival and hospital admission rates, improvement 
in hypoventilation symptoms, and a comparison between 
invasive and noninvasive ventilation.29
The timing of noninvasive ventilation therefore depends 
very much on the specific indication (Table 6) and the 
particular setting (acute versus domiciliary). It also very 
much depends on the underlying disease. For example, 
in Duchenne muscular dystrophy, there is a predictable 
disease course which starts with rapid eye movement-
related sleep-disordered breathing, followed by nonrapid 
eye movement and rapid eye movement sleep-disordered 
breathing and, finally, daytime respiratory failure with 
a gradual reduction in forced vital capacity through all 
stages.21 Therefore, it is possible to predict when a patient 
may need to commence noninvasive ventilation, and it is 
currently felt that in the presence of nocturnal hypoven-
tilation, daytime respiratory failure is almost inevitable, 
and so this may be an opportune moment to commence 
noninvasive ventilation.21
The American Academy of Neurology in 2009 produced 
evidenced-based guidelines on amyotrophic lateral sclerosis 
which recommends the use of noninvasive ventilation to treat 
respiratory failure because it probably lengthens   survival, 
slows the rate of decline in forced viral   capacity, and improves 
quality of life.30 It also recommends commencing noninva-
sive ventilation as soon as there is any evidence of nocturnal 
hypoventilation or respiratory insufficiency because this 
improves compliance.30 In patients with amyotrophic lateral 
sclerosis and bulbar involvement, it is felt that noninvasive 
ventilation should be trialed but stopped if there is no symp-
tomatic benefit because patients are less likely to be compliant 
and the survival benefit is reduced in the presence of bulbar 
involvement.21
It is evident that there is no set way of managing patients 
with neuromuscular disorders and respiratory insufficiency, so 
patients should be evaluated in respiratory centers with appro-
priate experience. Figure 2 is a suggested pathway, but the 
specific timing of noninvasive ventilation very much depends 
on the underlying disease and the specific   characteristics of the 
patient. Some patients may not be candidates for noninvasive 
ventilation, especially if they are having difficulty with respi-
ratory secretions or have a reduced conscious level.
Other considerations
Patients with pneumonia who are having difficulty clearing 
their secretions will benefit from chest physiotherapy, both 
from the hypoxia and comfort points of view, whether the 
patient is for active management or for palliation only. There 
may also be a role for cough assist devices in selected patients. 
Normal daytime PaO2 and PaCO2
Nocturnal hypoventilation in rapid eye
movement (sleep)
Nocturnal hypoventilation in non-REM sleep
Chronic daytime ventilatory failure
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Figure 1 Effect of progressive respiratory muscle weakness on nocturnal and diurnal 
ventilation.
Note: Reproduced with permission from the American College of Chest Physicians. 
Simonds A. Recent advances in respiratory care for neuromuscular disease. Chest. 
2006;130:1879–1886.21
Abbreviation: REM, rapid eye movement.
Table 6 Possible roles for noninvasive ventilation in patients with 
neuromuscular disorders21
Acute respiratory failure secondary to chest infection
Perioperative support/Peg tube placement
Sleep-disordered breathing
During pregnancy
To treat hypercapnic chronic respiratory failure
Palliate symptoms as part of end-of-life care
Complaint of fatigue,
daytime somnolence,
restless sleep/snoring,
morning headache
Patient with NMD presents
acutely with respiratory failure
stabilize patient/treat
precipitant
Pulmonary function tests (including supine FVC, mouth pressures),
overnight oximetry/polysomnography, arterial gases*
A
b
n
o
r
m
a
l
N
o
r
m
a
l
Evidence of SDB including nocturnal
hypoventilation-consider NIV
daytime respiratory insufficiency-NIV
OSA-CPAP
Monitor patient with PFTs/regular clinical
assessment. Frequency depends on
underlying NMD (eg, rapidly
progressing eg, post-polio syndrome)
and clinical suspicion.
Figure  2  Suggested  pathway  for  investigating  and  managing  patients  with  a 
neuromuscular disorder and respiratory insufficiency. 
Notes: *Depends on oxygen saturations and clinical suspicion of daytime hypercapnoea.
Adapted  from  Upinder  K,  Dhand  K,  Dhand.  Sleep  disorders  in  neuromuscular 
diseases. Curr Opin Pulm Med. 2006;12:402–408. 
Abbreviations:  FvC,  forced  vital  capacity;  NMD,  neuromuscular  disorder; 
OSA, obstructive sleep apnea; CPAP, continuous positive airways pressure; NIv, 
noninvasive ventilation; SDB, sleep-disordered breathing.
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Speech and language therapists should be involved to 
supervise swallow assessment, and dieticians need to be 
involved to optimize nutrition during an acute insult, whether 
it is via the nasogastric or oral route. Many patients with 
neuromuscular disorders may never recover their swallowing 
ability, and so long-term feeding options such as PEG feeding 
would need to be considered. Once their acute illness has 
been treated, further rehabilitation will be required, including 
physiotherapy and occupational therapy.
Patients known to have a progressive neuromuscular 
disorder with respiratory muscle involvement should 
have early discussions about their future wishes regarding 
  ventilation. This is really about quality of life and dignity, and 
an advanced treatment plan should be formulated whilst the 
patient can still communicate and has capacity. In advanced 
disease, palliative care should run side by side with active 
management, and it should be recognized that maintaining 
quality of life rather than undertaking aggressive intervention 
can be in the patient’s best interests.5
Conclusion
Early recognition of respiratory failure in patients with 
neuromuscular disease is essential for avoiding emergency 
intubation. In the acute setting, it is paramount that the treating 
clinician is decisive in order to avoid cardiorespiratory arrest, 
because deterioration can be rapid and fatal. It is important to 
recognize exacerbating factors like infection and aspiration. 
Improvement in understanding of the mechanism(s) of 
respiratory failure, better diagnostic tests, and provision of 
earlier ventilation, including home ventilation, has helped to 
prolong survival of patients with neuromuscular disorders 
which previously led to early morbidity and mortality.21 This 
is an area that requires further research to establish clearer 
practice on when to start noninvasive ventilation and the 
mode of noninvasive ventilation to be used. There is also a 
role for tracheostomy ventilation in certain patient groups 
including amyotrophic lateral sclerosis, but patient selection 
is crucially important in order to identify those who will 
benefit most, appreciating the psychological burden it can 
entail and the significant support and resources required. 
Finally, it remains important to have open discussions about 
the patient’s wishes with regard to end-of-life care to avoid 
treatments that can compromise patient dignity and impact 
adversely on their quality of life.
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